Literature DB >> 11341141

New advances in the management of acute coronary syndromes.

P W Armstrong1.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11341141      PMCID： PMC81022     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  Risk stratifying acute coronary syndromes: gradient of risk and benefit.

Authors:  C W Hamm
Journal:  Am Heart J       Date:  1999-07       Impact factor: 4.749

2.  New advances in the management of acute coronary syndromes: 1. Matching treatment to risk.

Authors:  D Fitchett; S Goodman; A Langer
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

Review 3.  Frontiers in interventional cardiology.

Authors:  E J Topol; P W Serruys
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

Review 4.  Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence.

Authors:  E J Topol
Journal:  Circulation       Date:  1998-01-20       Impact factor: 29.690

Review 5.  Acute coronary syndromes: unstable angina and non-Q-wave myocardial infarction.

Authors:  P Théroux; V Fuster
Journal:  Circulation       Date:  1998-03-31       Impact factor: 29.690

Review 6.  Low-molecular-weight heparins.

Authors:  J I Weitz
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

Review 7.  Thrombolysis for acute myocardial infarction.

Authors:  H D White; F J Van de Werf
Journal:  Circulation       Date:  1998-04-28       Impact factor: 29.690

8.  Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

Authors:  E Boersma; K S Pieper; E W Steyerberg; R G Wilcox; W C Chang; K L Lee; K M Akkerhuis; R A Harrington; J W Deckers; P W Armstrong; A M Lincoff; R M Califf; E J Topol; M L Simoons
Journal:  Circulation       Date:  2000-06-06       Impact factor: 29.690

9.  Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb Investigators.

Authors:  P W Armstrong; Y Fu; W C Chang; E J Topol; C B Granger; A Betriu; F Van de Werf; K L Lee; R M Califf
Journal:  Circulation       Date:  1998-11-03       Impact factor: 29.690
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.